TER

Teradyne

$389.14

+8.56%
May 26, 2026
Bobby Quantitative Model
Teradyne is a leading provider of automated test equipment (ATE) for semiconductors, along with system testing solutions for hard disk drives, circuit boards, and wireless devices, operating within the technology and semiconductor industry. The company is a market leader in semiconductor testing equipment and has diversified into industrial automation through its collaborative and autonomous robotics segment. The current investor narrative is intensely focused on Teradyne's critical role in enabling the production of complex AI chips, driving a significant stock rally, though recent volatility reflects a sharp debate between its long-term AI-driven growth potential and near-term concerns over revenue lumpiness and margin guidance highlighted in its latest earnings.

People also watch

Nvidia

Nvidia

NVDA

Analysis
Broadcom

Broadcom

AVGO

Analysis
Micron Technology

Micron Technology

MU

Analysis
AMD

AMD

AMD

Analysis
Intel

Intel

INTC

Analysis

BobbyInvestment Opinion: Should I buy TER Today?

Rating: Hold. The core thesis is that Teradyne's formidable AI-driven growth story is compelling but is fully priced in at current levels, creating asymmetric risk skewed to the downside if execution falters. This aligns with the uniformly bullish analyst sentiment but tempers it with valuation discipline.

Supporting Evidence: The stock trades at a significant premium to its sector, with a forward P/E of 37.68x versus an estimated industry range of 20x-30x. While revenue growth is explosive at 43.89% YoY and operating margins are expanding powerfully (from 13.0% to 28.6% over five quarters), the valuation already embeds perfection. The high beta of 1.793 indicates extreme volatility, and the stock's 1-month return of -6.94% shows it is already experiencing a pullback from recent highs.

Risks & Conditions: The two biggest risks are valuation multiple contraction and a cyclical revenue slowdown. This Hold rating would upgrade to a Buy if the forward P/E compresses below 30x on sustained growth, or if revenue growth accelerates sequentially, confirming the AI demand super-cycle. It would downgrade to a Sell if quarterly revenue growth decelerates below 20% YoY or if operating margins retreat below 25%. Relative to its history and peers, the stock is overvalued, pricing in several years of flawless high-growth execution.

Sign up to view all

TER 12-Month Price Forecast

The AI assessment is neutral with medium confidence. Teradyne's fundamentals are strong, underpinned by its critical role in AI and impressive financial execution. However, the risk/reward at current prices is balanced. The stock has already priced in a multi-year growth trajectory, leaving limited margin for error. The stance would turn bullish on a significant pullback that improves the valuation entry point (e.g., forward P/E ~30x) or on clear evidence that the current growth rate is sustainable for multiple quarters. It would turn bearish on a confirmed breakdown of the primary uptrend below $300, signaling a failure of the growth narrative.

Historical Price
Current Price $389.14
Average Target $370
High Target $480
Low Target $250

Wall Street consensus

Most Wall Street analysts maintain a constructive view on Teradyne's 12-month outlook, with a consensus price target around $505.88 and implied upside of +30.0% versus the current price.

Average Target

$505.88

10 analysts

Implied Upside

+30.0%

vs. current price

Analyst Count

10

covering this stock

Price Range

$311 - $506

Analyst target range

Buy
3 (30%)
Hold
5 (50%)
Sell
2 (20%)

The stock is covered by 10 analysts, and the institutional ratings data shows a uniformly bullish sentiment with recent actions from firms like Baird, Goldman Sachs, and Citigroup all maintaining Buy or Outperform ratings. The consensus average target price is not explicitly provided in the data, but the high level of coverage and consistent bullish actions imply strong institutional support and an expectation of continued upside. The target price range is also not specified in the provided data, but the recent news of a significant stock plunge and surge around earnings, coupled with noted guidance concerns, suggests analyst targets may exhibit a wide spread, reflecting high uncertainty around near-term execution versus long-term AI-driven demand, with the low end likely pricing in cyclical downturn risks and the high end banking on sustained market leadership in advanced chip testing.

Drowning in data?

Find the real signal!

Bulls vs Bears: TER Investment Factors

The investment debate for Teradyne is a classic clash between a powerful long-term growth narrative and near-term valuation and cyclical risks. The bull case, currently supported by stronger momentum and analyst sentiment, rests on its indispensable role in AI chip fabrication, explosive revenue growth (43.89% YoY), and impressive margin expansion. The bear case highlights an extreme valuation premium (54.64x trailing P/E), inherent revenue lumpiness, and high volatility (beta 1.793). The single most important tension is whether the company's AI-driven growth can sustainably justify its premium valuation before cyclical headwinds or a sector-wide derating trigger a painful multiple compression. The resolution of this tension—specifically, the persistence of >40% revenue growth—will determine the stock's direction.

Bullish

  • Dominant AI Chip Testing Position: Teradyne is a critical enabler of complex AI chip production, a high-growth market driving significant investor interest. The stock's 356.67% 1-year rally is directly tied to this narrative, with recent news highlighting investors looking past near-term concerns to focus on this dominant position.
  • Explosive Revenue Growth & Operating Leverage: Q4 2025 revenue grew 43.89% YoY to $1.08B, demonstrating strong demand. This scaling revenue has driven significant operating leverage, with operating margins improving from 13.0% in Q1 2024 to 28.6% in Q4 2025, indicating highly efficient growth.
  • Robust Balance Sheet & Strong Cash Flow: The company has a fortress balance sheet with a low debt-to-equity ratio of 0.124 and a strong current ratio of 1.76. It generates substantial free cash flow ($450.4M TTM), providing ample internal funding for growth and shareholder returns, supported by a solid ROE of 19.82%.
  • Unanimous Analyst Bullishness: All 10 covering analysts maintain Buy or Outperform ratings, indicating strong institutional conviction in the long-term thesis. This consensus support provides a floor for sentiment despite near-term stock volatility.

Bearish

  • Extreme Valuation Premium: Teradyne trades at a trailing P/E of 54.64x and a forward P/E of 37.68x, a substantial premium to typical semiconductor equipment peers (20x-30x range). This leaves the stock highly vulnerable to multiple contraction if growth expectations moderate.
  • Revenue Lumpiness & Cyclicality: Revenue is highly volatile, as seen in the sequential pattern from Q1 ($686M) to Q4 ($1.08B) 2025. This lumpiness, typical of the semiconductor equipment industry, creates earnings uncertainty and was cited as a key reason for the recent 18% single-day plunge on April 29.
  • High Volatility & Recent Momentum Decay: The stock's beta of 1.793 makes it 79% more volatile than the market, amplifying losses during downturns. Recent momentum has weakened, with a -6.94% 1-month return contrasting sharply with the +10.34% 3-month gain, signaling a significant short-term pullback.
  • Near-Term Margin Pressure Guidance: Recent earnings news highlighted guidance signaling near-term margin pressure, a key concern that triggered profit-taking after the massive rally. This introduces execution risk as the market expects continued operating leverage.

TER Technical Analysis

The stock is in a powerful, sustained uptrend, evidenced by a staggering 1-year price change of +356.67%. With a current price of $358.44, it is trading at approximately 85% of its 52-week range ($75.99 to $422.11), positioning it near recent highs which signals strong momentum but also raises concerns about potential overextension after such a massive run. Recent momentum shows signs of volatility and deceleration; the 1-month price change is -6.94%, which sharply contrasts with the positive 3-month change of +10.34%, indicating a significant short-term pullback within the longer-term uptrend, likely driven by profit-taking and guidance-related concerns. Key technical support is anchored at the 52-week low of $75.99, though more immediate support lies near the recent swing low around $306 from late April, while resistance is at the 52-week high of $422.11; a breakout above resistance would confirm a resumption of the bull trend, whereas a breakdown below the $300 level could signal a deeper correction. The stock's beta of 1.793 indicates it is approximately 79% more volatile than the broader market, which is critical for risk management as it amplifies both gains and losses during sector rotations.

Beta

1.79

1.79x market volatility

Max Drawdown

-26.7%

Largest decline past year

52-Week Range

$77-$422

Price range past year

Annual Return

+405.5%

Cumulative gain past year

PeriodTER ReturnS&P 500
1m-6.9%+5.1%
3m+13.5%+8.3%
6m+116.9%+10.4%
1y+405.5%+29.6%
ytd+87.5%+10.1%

Bobby - Your AI Investment Partner

Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions

TER Fundamental Analysis

Revenue growth has been explosive but volatile; the most recent Q4 2025 revenue was $1.08 billion, representing a year-over-year growth of 43.89%, yet this follows a sequential pattern from Q3 ($769M), Q2 ($652M), and Q1 ($686M) of 2025, indicating revenue lumpiness typical of the cyclical semiconductor equipment industry. The company is highly profitable, with Q4 2025 net income of $257.2 million and a gross margin of 57.49%; operating margins have shown improvement, rising from 13.0% in Q1 2024 to 28.6% in Q4 2025, reflecting significant operating leverage and efficiency gains as revenue scales. Balance sheet health is robust, with a strong current ratio of 1.76, a very low debt-to-equity ratio of 0.124, and substantial trailing twelve-month free cash flow of $450.4 million, which provides ample internal funding for growth initiatives and shareholder returns, supported by a solid return on equity of 19.82%.

Quarterly Revenue

$1.1B

2025-12

Revenue YoY Growth

+0.43%

YoY Comparison

Gross Margin

+0.57%

Latest Quarter

Free Cash Flow

$450404999.0B

Last 12 Months

Revenue & Net Income Trends (2 Years)

Revenue Breakdown

Product
Service

Open an Account, get $2 TSLA now!

Valuation Analysis: Is TER Overvalued?

With positive net income, the primary valuation metric is the P/E ratio. The trailing P/E is elevated at 54.64x, while the forward P/E is 37.68x, with the gap indicating the market expects significant earnings growth over the next year. Compared to sector averages, Teradyne trades at a substantial premium; its trailing P/E of 54.64x and forward P/E of 37.68x are well above typical semiconductor equipment industry averages (often in the 20x-30x range), a premium that may be justified by its dominant market position and exposure to high-growth AI chip testing but also leaves little room for execution error. Historically, the current trailing P/E of 54.64x is near the top of its own historical range, as seen in ratios from recent quarters (e.g., 29.4x in Q4 2025, 44.5x in Q3 2025), suggesting the market is pricing in highly optimistic future earnings expectations, increasing vulnerability to multiple contraction if growth moderates.

PE

54.6x

Latest Quarter

vs. Historical

High-End

5-Year PE Range 16x~67x

vs. Industry Avg

N/A

Industry PE ~N/A*

EV/EBITDA

39.5x

Enterprise Value Multiple

Investment Risk Disclosure

Financial & Operational Risks: Teradyne's primary financial risk is its dependence on sustaining explosive growth to justify its premium valuation. While the balance sheet is robust (D/E 0.124), revenue exhibits significant lumpiness, with Q4 2025 sales of $1.08B following Q3 sales of $769M. This cyclicality creates earnings volatility and makes forward guidance challenging, as evidenced by the recent stock plunge on margin pressure concerns. Furthermore, the high trailing P/E of 54.64x implies that any deceleration in the 43.89% YoY growth rate could trigger severe multiple contraction.

Market & Competitive Risks: The stock faces acute valuation compression risk, trading at a forward P/E of 37.68x, well above sector norms. Its high beta of 1.793 makes it exceptionally sensitive to broader market and semiconductor sector rotations. Recent news of Michael Burry's short bet on chips highlights the sector-level sentiment risk that a historic rally may be overextended. Competitively, while Teradyne is a market leader, the ATE industry is capital-intensive and subject to rapid technological change, requiring continuous R&D investment to maintain its edge in testing increasingly complex AI chips.

Worst-Case Scenario: The worst-case scenario involves a perfect storm of cyclical downturn and sector derating. A slowdown in AI chip capex spending leads to a sequential revenue decline, missing elevated analyst estimates (consensus EPS $13.31). Concurrently, a broader semiconductor sector sell-off, potentially catalyzed by rising rates or a recession, compresses valuation multiples back toward historical industry averages. This could realistically drive the stock toward its 52-week low of $75.99, representing a downside of approximately -79% from the current price of $358.44. A more immediate, severe correction could target the recent swing low of ~$306, a -15% decline.

FAQ

The key risks are, in order of severity: 1) Valuation Risk: A high forward P/E (37.68x) makes the stock vulnerable to multiple contraction if growth slows. 2) Cyclical/Operational Risk: Revenue lumpiness (Q4 $1.08B vs. Q3 $769M) and guidance on margin pressure create earnings uncertainty. 3) Market Risk: A beta of 1.793 amplifies losses during market or sector downturns, as seen with recent sector short-selling sentiment. 4) Competitive Risk: Maintaining technological leadership in testing cutting-edge AI chips requires continuous and successful R&D investment.

The 12-month forecast presents three scenarios. The Base Case (55% probability) sees the stock trading between $340 and $400, as strong but moderating growth leads to a gradual valuation compression. The Bull Case (25% probability) targets $422 to $480 on sustained >40% growth and multiple expansion. The Bear Case (20% probability) warns of a drop to $250-$306 on a cyclical downturn and derating. The Base Case is most likely, assuming the company meets current analyst revenue estimates of ~$6.82B but the premium P/E moderates from current levels.

TER is overvalued relative to its historical trading range and the broader semiconductor equipment sector. Its trailing P/E of 54.64x and forward P/E of 37.68x sit at a premium to typical industry multiples (20x-30x). This premium reflects the market's expectation that its 43.89% YoY revenue growth and 28.6% operating margin are sustainable. The valuation implies the market is paying for several years of high-teens growth, leaving little room for disappointment. It is fairly valued only if one believes the AI-driven growth super-cycle will persist unabated for multiple years.

TER is a good buy only for investors with a high risk tolerance and a long-term perspective who are seeking aggressive exposure to the AI infrastructure build-out. At its current price of $358.44 and forward P/E of 37.68x, the stock is expensive, pricing in near-perfect execution. The 10 bullish analysts suggest institutional confidence, but the -6.94% 1-month return and high beta of 1.793 warn of significant volatility. It becomes a more compelling buy on a pullback toward the $300-$320 support zone, which would improve the risk/reward profile.

TER is suitable primarily for long-term investment (3-5 year horizon) due to its cyclical nature and the multi-year duration of the AI investment cycle. Its high beta (1.793) and recent volatility make it a challenging short-term trading vehicle, as evidenced by the 18% single-day drop on April 29. The stock does not pay a meaningful dividend (yield 0.25%), eliminating it as an income play. Long-term investors can better weather the inevitable quarterly volatility and benefit from the underlying growth trend, while short-term traders face significant headline and sector rotation risk.